FDA: Lower Maximum Daily Dose of Celexa to Protect Heart
Monday August 29, 2011
The Food and Drug Administration (FDA) says high-dosing of the antidepressant citalopram hydrobromide, marketed under the brand name Celexa or the generic citalopram, carries a risk of heart arrhythmias.
The ... Read More
Canadian Pharmacy, US Seniors Groups Seek Alternative to Blanket Ban on Canadian Online Drug Advertising
Sunday August 28, 2011
Google and other search engines should be allowed to develop clear policies for the safe importation of prescription drugs into the United States rather than banning all online pharmacies, according ... Read More
Industry Grows Restless Waiting for FDA's Social Media Guidance
Wednesday August 17, 2011
Illustration: liako
How can the pharmaceutical industry use social media while complying with regulations regarding marketing prescription medications?
The UK's Prescription Medicines Code of Practice Authority (PMCPA), has issued "informal ... Read More
FDA Approves Complera, a Daily Pill for HIV
Saturday August 13, 2011
Complera, a new drug therapy for Human Immunodeficiency Syndrome, HIV, gained U.S. Food and Drug Administration (FDA) approval August 10. The drug combo -- emtricitabine/rilpivirine/tenofovir disoproxil fumarate - brings ... Read More
FDA to Address Drug Shortages
Tuesday August 9, 2011
A record number of drug shortages occurred in 2010 and the pattern continues in 2011. A majority of the shortages - 132 out of 178 reported in 2010 - occurred ... Read More
GlaxoSmithKline's Iraq Deal
Sunday August 7, 2011
Iraq remains a dangerous place to live and do business due to ongoing violence and political instability. But that isn't stopping impatient investors anxious to take part in the nation's ... Read More
Pharma Exec: Industry Consolidation Hurts Drug Research
Saturday August 6, 2011
John LaMattina isn't the first insider to state that mergers and acquisitions are hurting the pharmaceutical industry, but he may be one of the most highly placed.
In the August ... Read More
Johnson & Johnson to Phase in Lower Dosing of Tylenol Products
Monday August 1, 2011
Johnson & Johnson will begin following an FDA committee's recommendation to lower the daily adult dose of acetaminophen from 4000 mg to 3000 mg (from eight to six pills) on ... Read More